Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study

Abstract

BackgroundExcept for overall survival, whether or not waiting time for treatment could influences other domains of cancer patients’ overall well-being is to a large extent unknown. Therefore, we performed this study to determine the effect of waiting time for cancer treatment on the mental health of patients with esophageal or gastric cancer.MethodsBased on the Swedish National Quality Register for Esophageal and Gastric Cancers (NREV), we followed 7,080 patients diagnosed 2006–2012 from the time of treatment decision. Waiting time for treatment was defined as the interval between diagnosis and treatment decision, and was classified into quartiles. Mental disorders were identified by either clinical diagnosis through hospital visit or prescription of psychiatric medications. For patients without any mental disorder before treatment, the association between waiting time and subsequent onset of mental disorders was assessed by hazard ratios (HRs) with 95% confidence interval (CI), derived from multivariable-adjusted Cox model. For patients with a preexisting mental disorder, we compared the rate of psychiatric care by different waiting times, allowing for repeated events.ResultsAmong 4,120 patients without any preexisting mental disorder, lower risk of new onset mental disorders was noted for patients with longer waiting times, i.e. 18–29 days (HR 0.86; 95% CI 0.74-1.00) and 30–60 days (HR 0.79; 95% CI 0.67-0.93) as compared with 9–17 days. Among 2,312 patients with preexisting mental disorders, longer waiting time was associated with more frequent psychiatric hospital care during the first year after treatment (37.5% higher rate per quartile increase in waiting time; p for trend = 0.0002). However, no such association was observed beyond one year nor for the prescription of psychiatric medications.ConclusionsThese data suggest that waiting time to treatment for esophageal or gastric cancer may have different mental health consequences for patients depending on their past psychiatric vulnerabilities. Our study sheds further light on the complexity of waiting time management, and calls for a comprehensive strategy that takes into account different domains of patient well-being in addition to the overall survival.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-016-3013-7) contains supplementary material, which is available to authorized users.

Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer

“…The results of this study do not imply that treatment should be delayed without reason. A prolonged pretreatment wait time has been shown to cause psychological distress [25] and deteriorated quality of life and satisfaction [26], and it is associated with frequent psychiatric hospital care after treatment in patients with preexisting mental disorders [27]. If a prolonged preoperative wait time is needed for the assessment and control of comorbidities, surgeons should pay close attention and should start treatment as early as possible.…”

Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer

“…Participants were recruited for the prospective, longitudinal AYA-LE study [ 24 ] at 16 acute care hospitals, four rehabilitation clinics, and from two state tumor registries in Germany. In addition, other interested patients could register themselves via the internet or telephone.…”

Health professionals’ perceptions of colorectal cancer patients’ treatment burden and their supportive work to ameliorate the burden - a qualitative study

“…Norwegian cancer care pathways for CRC have an ideal short timeframe from diagnosing symptoms to initiating treatment with the aim to ensure high-quality cancer care [5]. Although waiting time is associated with significant concerns for cancer patients and delay of treatment may have an especially substantial psychological impact on patients [35], it is likely some patients experience a fast cancer care trajectory as stressful and challenging to keep up with. A structured treatment pathway may represent a treatment burden to cancer patients, requiring the patients to adapt to the pace of the treatment trajectory and set aside the demands of everyday life [10].…”